Urgent transcatheter edge-to-edge mitral valve repair (TEER) may offer a therapeutic alternative for patients with cardiogenic shock due to severe mitral regurgitation (MR). We reviewed 23 high-risk patients undergoing urgent TEER. Procedural success was 100%, with marked MR reduction and low periprocedural complication rates. Thirty-day and 1-year mortality were 17.4% and 30.4%, respectively. Among survivors with follow-up data, most demonstrated sustained symptomatic improvement. Percutaneous TEER may potentially serve as either definitive therapy or a temporizing intervention for patients in cardiogenic shock with prohibitive surgical risk while preserving the option for subsequent surgical mitral repair after improvement in clinical status.
Ahmed et al. (Sun,) studied this question.